Benchmark analyst maintained a Hold rating on shares of Neogenomics (NASDAQ: NEO). The analysis comes ahead of the company's investor conference presentation scheduled for the same day. The company, ...
Follow here to see if Wall Street can add to the big gains seen midweek after cooler inflation saw Treasury yields plunge, ...
Asian shares mostly rose Thursday, following a rally on Wall Street driven by encouraging update on U.S. inflation. Japan's ...
Poland’s central bank has revealed its reluctance to cut interest rates before the end of this year, as a number of economic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback